Concepedia

Mir Lim

ML

8

Publications

224

Citations

8

H-Index

2020

Active since

Affiliations

The University of Texas Southwestern Medical Center(Current)

National Yang Ming Chiao Tung University

Taipei Veterans General Hospital

Harvard University

Guardant (United States)

Mir Lim is an author at The University of Texas Southwestern Medical Center specializing in hepatology, radiation oncology, and immunology.

ORCID

Top concepts

Publications per year

2020–2025

8

Publications

8

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

Bernhard Scheiner, Daniel Roessler, Samuel Phen et al. · JHEP Reports · 2022 · 56 citations · Full text

, , +7

Disease Etiology and Outcomes After Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma: Post-Hoc Analysis of IMbrave150

Magdalena Espinoza, Maishara Muquith, Mir Lim et al. · Gastroenterology · 2023 · 48 citations

, , +8

Off‐label prescribing of targeted anticancer therapy at a large pediatric cancer center

Mir Lim, David S. Shulman, Holly Roberts et al. · Cancer Medicine · 2020 · 35 citations · Full text

Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

Stephanie Alden, Mir Lim, Chester Kao et al. · Cancer Research Communications · 2023 · 29 citations · Full text

Surrogate and modified endpoints for immunotherapy in advanced hepatocellular carcinoma

Mir Lim, Maishara Muquith, Bernadette Miramontes et al. · Hepatology · 2023 · 21 citations

Rows per page

1–5 of 8